Stephen Mackinnon
- Hematology top 0.05%
- Hematopoietic Stem Cell Transplantation 96
- Chronic Myeloid Leukemia Treatments 34
- Immunology top 0.5%
- Immune Cell Function and Interaction 43
- T-cell and B-cell Immunology 32
- Transplantation top 0.5%
- Oncology top 0.5%
- Viral-associated cancers and disorders 26
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 30
-
- Cytomegalovirus and herpesvirus research 47
-
- Lymphoma Diagnosis and Treatment 35
- Co-authors
- Karl S. PeggsKirsty ThomsonDavid C. LinchAnthony H. GoldstoneStephanie VerfuerthFarid BouladHugo Castro‐MalaspinaEmma Morris
- Cited by
- HematologyImmunologyTransplantation
- Journals
- Blood (58 papers)British Journal of Haematology (23 papers)Bone Marrow Transplantation (21 papers)
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
Stephen Mackinnon
193 papers receiving 9.6k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Hematology 5.3k
- Immunology 4.1k
- Transplantation 455
- Oncology 3.5k
- Genetics 1.2k
Countries citing papers authored by Stephen Mackinnon
This map shows the geographic impact of Stephen Mackinnon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Mackinnon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Mackinnon more than expected).
Fields of papers citing papers by Stephen Mackinnon
This network shows the impact of papers produced by Stephen Mackinnon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Mackinnon. The network helps show where Stephen Mackinnon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stephen Mackinnon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 159 | |
| 2 | The role of V delta 2-negative gamma delta T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation | 2010 | 6 |
| 3 | Reduced intensity allogeneic stem cell transplantation in patients with myelofibrosis | 2006 | 1 |
| 4 | Graft-versus-host disease of the liver: 109 cases from a single-centre | 2004 | 1 |
| 5 | Long term results of reduced intensity transplantation in multiply relapsed and refractory Hodgkin's lymphoma: Evidence of a therapeutically relevant graft-versus-lymphoma effect. | 2003 | 5 |
| 6 | Long-term follow-up of an alemtuzumab (CAMPATH-1H) containing reduced intensity allogeneic transplant regimen for non-Hodgkin's lymphoma (NHL). | 2002 | 2 |
| 7 | Reduced intensity conditioned allografts for myeloma : A study from the Chronic Leukaemia Working Party of the EBMT. | 2002 | 1 |
| 8 | 2002 | 30 | |
| 9 | Cytomegalovirus-specific adoptive cellular therapy results in massive and persistent expansions of CMV-specific T-cells and significantly reduces the incidence of CMV reactivation following allogeneic transplantation. | 2001 | 2 |
| 10 | Non-myeloablative transplantation for patients with Hodgkin's disease: Limited transplant related mortality and possible evidence of a graft versus Hodgkin's effect. | 2001 | 4 |
| 11 | Higher than expected transplant-related mortality and relapse following nonmyeloablative stem cell transplantation for lymphoma adversely effects progression free survival. | 2000 | 4 |
| 12 | Excellent outcome of non-myeloablative stem cell transplant (NMSCT) for good risk myeloma: The EBMT experience | 2000 | 12 |
| 13 | The importance of patient selection in nonmyeloablative stem cell transplant (NMSCT) for acute and chronic leukaemia, myelodysplastic syndrome, and myeloma | 2000 | 2 |
| 14 | 1999 | 6 | |
| 15 | 1999 | 23 | |
| 16 | Allogeneic transplantation following failure of autologous transplantation for lymphoma. | 1998 | 3 |
| 17 | Matched unrelated donor bone marrow transplantation for chronic myeloid leukaemia in chronic phase: comparison of ex vivo and in vivo T-cell depletion. | 1993 | 8 |
| 18 | BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOID-LEUKEMIA (CML) USING MATCHED UNRELATED DONORS | 1988 | 1 |
| 19 | HISTOCOMPATIBLE UNRELATED VOLUNTEER DONORS FOR BMT IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA | 1988 | 1 |
| 20 | 1986 | 7 |
About Stephen Mackinnon
Stephen Mackinnon is a scholar working on Hematology, Transplantation, Genetics, Immunology and Oncology, having authored 196 papers that have together received 9.7k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (96 papers), Cytomegalovirus and herpesvirus research (47 papers), Immune Cell Function and Interaction (43 papers), Lymphoma Diagnosis and Treatment (35 papers), Chronic Myeloid Leukemia Treatments (34 papers), T-cell and B-cell Immunology (32 papers), Chronic Lymphocytic Leukemia Research (30 papers) and Viral-associated cancers and disorders (26 papers). The work is most often cited by research in Hematology (5.3k citations), Immunology (4.1k citations), Transplantation (455 citations), Oncology (3.5k citations) and Genetics (1.2k citations). Stephen Mackinnon has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Karl S. Peggs, Kirsty Thomson, David C. Linch, Anthony H. Goldstone, Stephanie Verfuerth, Farid Boulad, Hugo Castro‐Malaspina, Emma Morris, Ronjon Chakraverty and Panagiotis Kottaridis. Their work appears in journals such as Blood, British Journal of Haematology, Bone Marrow Transplantation, Biology of Blood and Marrow Transplantation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.